TYLER MILLER: Open Payments
NPI 1578277646 · YOUNGSVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 31 payments from 14 companies in 2025. Trend: 2023 $958 · 2024 $506 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $124 |
| Corium, LLC | 4 | $90 |
| ABBVIE INC. | 4 | $67 |
| PFIZER INC. | 2 | $39 |
| Novo Nordisk Inc | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 4 | $28 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Exact Sciences Corporation | 1 | $17 |
Products named: Azstarys, MOUNJARO, JARDIANCE, Wegovy, UBRELVY, VOQUEZNA, NURTEC ODT, NEXLETOL.
Industry payments across LA — which companies pay providers there.
